Clinically Proven NMN Get Uthever® NMN Whitepaper

Overview


EFFEPHARM LTD

NMN is a precursor to NAD+. NAD+ is crucial for energy production, DNA repair, and regulating various cellular processes.

The FDA has officially recognized NMN’s lawful use in dietary supplements. Uthever® NMN is the first large-scale, clinically proven NMN brand, supported by extensive research to boost NAD levels and overall wellness. With this regulatory clarity, now is the perfect time to include Uthever® NMN into your product development.

Download the Uthever® NMN white paper for industry insights, the latest scientific findings on NMN, and comprehensive global regulatory information.

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

Uthever® NMN: Novel Food Approval Nearing Final Stage

Uthever® NMN: Novel Food Approval Nearing Final Stage

Paid for by Effepharm Ltd

White Paper

One Step Away from EU Market Compliance for NMN. The official positive opinion of Novel Food is expected to be published shortly, which means Uthever® NMN will be the first compliant ingredient.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.